Mitochondria: Roles in pulmonary hypertension

International Journal of Biochemistry and Cell Biology

Volumn 55, Issue , 2014, Pages 93-97

  Freund Michel, Véronique ^a,b   Khoyrattee, Nafiisha ^a,b   Savineau, Jean Pierre ^a,b   Muller, Bernard ^a,b   Guibert, Christelle ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CENTRE DE RECHERCHE CARDIO THORACIQUE DE BORDEAUX   (France)

Author keywords

Mitochondria; Mitochondrial dysfunction; Pulmonary arterial remodelling; Pulmonary hypertension; Right ventricular hypertrophy

Indexed keywords

ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; CALCIUM; CITRATE SYNTHASE; CITRIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLAVINE ADENINE NUCLEOTIDE; HISTONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MANGANESE SUPEROXIDE DISMUTASE; N(G),N(G) DIMETHYLARGININE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PROTEIN NOGO; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE KINASE; PYRUVIC ACID; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; UNCOUPLING PROTEIN 2;

ACTION POTENTIAL DURATION; ARTERY MUSCLE; ARTICLE; CALCIUM TRANSPORT; CELL FUNCTION; CITRIC ACID CYCLE; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; ENZYME ACTIVITY; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLYCOLYSIS; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART RIGHT VENTRICLE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HISTONE ACETYLATION; HUMAN; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE PHOSPHORYLATION UNCOUPLING; OXYGEN CONSUMPTION; PATHOGENESIS; PH; PULMONARY HYPERTENSION; UPREGULATION; VASCULAR ENDOTHELIUM; ANIMAL; BIOLOGICAL MODEL; HEART RIGHT VENTRICLE HYPERTROPHY; METABOLISM; OXIDATION REDUCTION REACTION; PULMONARY ARTERY;

ANIMALS; GLYCOLYSIS; HUMANS; HYPERTROPHY, RIGHT VENTRICULAR; MITOCHONDRIA; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION; PULMONARY ARTERY; REACTIVE OXYGEN SPECIES;

EID: 84906853811     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2014.08.012     Document Type: Short Survey

References (47)

1. S.L. Archer, Y.H. Fang, J.J. Ryan, and L. Piao Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension Pulm Circ 3 2013 144 152
2. S.L. Archer, G. Marsboom, G.H. Kim, H.J. Zhang, P.T. Toth, and E.C. Svensson et al. Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target Circulation 121 2010 2661 2671
3. H.J. Bogaard, R. Natarajan, S.C. Henderson, C.S. Long, D. Kraskauskas, and L. Smithson et al. Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure Circulation 120 2009 1951 1960
4. S. Bonnet, E.D. Michelakis, C.J. Porter, M.A. Andrade-Navarro, B. Thebaud, and S. Bonnet et al. An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension Circulation 113 2006 2630 2641
5. S. Bonnet, G. Rochefort, G. Sutendra, S.L. Archer, A. Haromy, and L. Webster et al. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted Proc Natl Acad Sci USA 104 2007 11418 11423
6. P. Crosswhite, and Z. Sun Molecular mechanisms of pulmonary arterial remodelling Mol Med 20 2014 191 201
7. P. Dromparis, and E.D. Michelakis Mitochondria in vascular health and disease Annu Rev Physiol 75 2013 95 126
8. P. Dromparis, R. Paulin, T.H. Stenson, A. Haromy, G. Sutendra, and E.D. Michelakis Attenuating endoplasmic reticulum stress as a novel therapeutic strategy in pulmonary hypertension Circulation 127 2013 115 125
9. P. Dromparis, R. Paulin, G. Sutendra, A.C. Qi, S. Bonnet, and E.D. Michelakis Uncoupling protein 2 deficiency mimics the effects of hypoxia and endoplasmic reticulum stress on mitochondria and triggers pseudohypoxic pulmonary vascular remodelling and pulmonary hypertension Circ Res 113 2013 126 136
10. P. Dromparis, G. Sutendra, and E.D. Michelakis The role of mitochondria in pulmonary vascular remodelling J Mol Med (Berl) 88 2010 1003 1010
11. E. Dumas de La Roque, N. Bellance, R. Rossignol, H. Begueret, M. Billaud, and P. dos Santos et al. Dehydroepiandrosterone reverses chronic hypoxia/reoxygenation-induced right ventricular dysfunction in rats Eur Respir J 40 2012 1420 1429
12. Y.H. Fang, L. Piao, Z. Hong, P.T. Toth, G. Marsboom, and P. Bache-Wiig et al. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle J Mol Med (Berl) 90 2012 31 43
13. I. Fijalkowska, W. Xu, S.A. Comhair, A.J. Janocha, L.A. Mavrakis, and B. Krishnamachary et al. Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells Am J Pathol 176 2010 1130 1138
14. V. Freund-Michel, C. Guibert, M. Dubois, A. Courtois, R. Marthan, and J.P. Savineau et al. Reactive oxygen species as therapeutic targets in pulmonary hypertension Ther Adv Respir Dis 7 2013 175 200
15. J. Gomez-Arroyo, S. Mizuno, K. Szczepanek, B. Van Tassell, R. Natarajan, and C.G. dos Remedios et al. Metabolic gene remodelling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension Circ Heart Fail 6 2013 136 144
16. C. Guarnieri, and C. Muscari Beneficial effects of trimetazidine on mitochondrial function and superoxide production in the cardiac muscle of monocrotaline-treated rats Biochem Pharmacol 37 1988 4685 4688
17. G. Marsboom, P.T. Toth, J.J. Ryan, Z. Hong, X. Wu, and Y.H. Fang et al. Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension Circ Res 110 2012 1484 1497
18. M.S. McMurtry, S. Bonnet, X. Wu, J.R. Dyck, A. Haromy, and K. Hashimoto et al. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis Circ Res 95 2004 830 840
19. D. Montani, S. Gunther, P. Dorfmuller, F. Perros, B. Girerd, and G. Garcia et al. Pulmonary arterial hypertension Orphanet J Rare Dis 8 2013 97
20. K.T. Mouchaers, I. Schalij, A.M. Versteilen, A.M. Hadi, G.P. van Nieuw Amerongen, and V.W. van Hinsbergh et al. Endothelin receptor blockade combined with phosphodiesterase-5 inhibition increases right ventricular mitochondrial capacity in pulmonary arterial hypertension Am J Physiol Heart Circ Physiol 297 2009 H200 H207
21. K. Nouette-Gaulain, M. Biais, J.P. Savineau, R. Marthan, J.P. Mazat, and T. Letellier et al. Chronic hypoxia-induced alterations in mitochondrial energy metabolism are not reversible in rat heart ventricles Can J Physiol Pharmacol 89 2011 58 66
22. K. Nouette-Gaulain, M. Malgat, C. Rocher, J.P. Savineau, R. Marthan, and J.P. Mazat et al. Time course of differential mitochondrial energy metabolism adaptation to chronic hypoxia in right and left ventricles Cardiovasc Res 66 2005 132 140
23. O. Pak, N. Sommer, T. Hoeres, A. Bakr, S. Waisbrod, and A. Sydykov et al. Mitochondrial hyperpolarization in pulmonary vascular remodelling. Mitochondrial uncoupling protein deficiency as disease model Am J Respir Cell Mol Biol 49 2013 358 367
24. I. Papandreou, R.A. Cairns, L. Fontana, A.L. Lim, and N.C. Denko HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption Cell Metab 3 2006 187 197
25. R. Paulin, and E.D. Michelakis The metabolic theory of pulmonary arterial hypertension Circ Res 115 2014 148 164
26. L. Piao, Y.H. Fang, K. Parikh, J.J. Ryan, P.T. Toth, and S.L. Archer Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension J Mol Med (Berl) 91 2013 1185 1197
27. L. Piao, G. Marsboom, and S.L. Archer Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure J Mol Med (Berl) 88 2010 1011 1020
28. L. Piao, V.K. Sidhu, Y.H. Fang, J.J. Ryan, K.S. Parikh, and Z. Hong et al. FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate J Mol Med (Berl) 91 2013 333 346
29. E.M. Redout, M.J. Wagner, M.J. Zuidwijk, C. Boer, R.J. Musters, and C. van Hardeveld et al. Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species Cardiovasc Res 75 2007 770 781
30. C.J. Rhodes, L.S. Howard, M. Busbridge, D. Ashby, E. Kondili, and J.S. Gibbs et al. Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights J Am Coll Cardiol 58 2011 300 309
31. C.J. Rhodes, J. Wharton, L. Howard, J.S. Gibbs, A. Vonk-Noordegraaf, and M.R. Wilkins Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target Eur Respir J 38 2011 1453 1460
32. N. Sud, S.M. Wells, S. Sharma, D.A. Wiseman, J. Wilham, and S.M. Black Asymmetric dimethylarginine inhibits HSP90 activity in pulmonary arterial endothelial cells: role of mitochondrial dysfunction Am J Physiol Cell Physiol 294 2008 C1407 C1418
33. X. Sun, S. Sharma, S. Fratz, S. Kumar, R. Rafikov, and S. Aggarwal et al. Disruption of endothelial cell mitochondrial bioenergetics in lambs with increased pulmonary blood flow Antioxid Redox Signal 18 2013 1739 1752
34. G. Sutendra, S. Bonnet, G. Rochefort, A. Haromy, K.D. Folmes, and G.D. Lopaschuk et al. Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodelling of pulmonary hypertension Sci Transl Med 2 2010 44ra58
35. G. Sutendra, P. Dromparis, S. Bonnet, A. Haromy, M.S. McMurtry, and R.C. Bleackley et al. Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFalpha contributes to the pathogenesis of pulmonary arterial hypertension J Mol Med (Berl) 89 2011 771 783
36. G. Sutendra, P. Dromparis, R. Paulin, S. Zervopoulos, A. Haromy, and J. Nagendran et al. A metabolic remodelling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension J Mol Med (Berl) 91 2013 1315 1327
37. G. Sutendra, P. Dromparis, P. Wright, S. Bonnet, A. Haromy, and Z. Hao et al. The role of Nogo and the mitochondria-endoplasmic reticulum unit in pulmonary hypertension Sci Transl Med 3 2011 88ra55
38. G. Sutendra, and E.D. Michelakis The metabolic basis of pulmonary arterial hypertension Cell Metab 19 2014 558 573
39. X. Tang, Y.X. Luo, H.Z. Chen, and D.P. Liu Mitochondria, endothelial cell function, and vascular diseases Front Physiol 5 2014 175
40. J.P. Ward, and I.F. McMurtry Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem Curr Opin Pharmacol 9 2009 287 296
41. W. Xu, and S.C. Erzurum Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension Compr Physiol 1 2011 357 372
42. W. Xu, T. Koeck, A.R. Lara, D. Neumann, F.P. DiFilippo, and M. Koo et al. Alterations of cellular bioenergetics in pulmonary artery endothelial cells Proc Natl Acad Sci USA 104 2007 1342 1347
43. M.E. Yeager, M.B. Reddy, C.M. Nguyen, K.L. Colvin, D.D. Ivy, and K.R. Stenmark Activation of the unfolded protein response is associated with pulmonary hypertension Pulm Circ 2 2012 229 240
44. J.X. Yuan, A.M. Aldinger, M. Juhaszova, J. Wang, J.V. Conte Jr., and S.P. Gaine et al. Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension Circulation 98 1998 1400 1406
45. N. Zamzami, and G. Kroemer The mitochondrion in apoptosis: how Pandora's box opens Nat Rev Mol Cell Biol 2 2001 67 71
46. L. Zhao, A. Ashek, L. Wang, W. Fang, S. Dabral, and O. Dubois et al. Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodelling targeted treatments Circulation 128 2013 1214 1224
47. L. Zhao, C.N. Chen, N. Hajji, E. Oliver, E. Cotroneo, and J. Wharton et al. Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid Circulation 126 2012 455 467